News Links
Press Releases from September 27, 2017
JDRF Funds Zucara Therapeutics’ Approach to Preventing Hypoglycemia in People with Type 1 Diabetes. Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL. See also FDA Tentatively Approves Sanofi’s New Fast-Acting Insulin Admelog.
Read MorePopular Press from September 27, 2017
Highworth’s Nate sets up Type 1 Diabetes group. The suicide note that told Megan’s diabulimia story. See also Diabulimia: what it’s like to live with diabetes and an eating disorder and Everything you need to know about diabulimia, the dangerous mix of diabetes and an eating disorder. UK families can watch “Diabulimia: The World’s Most Dangerous Eating Disorder” using the BBC Player. Ross Elementary raises more than 6K for juvenile diabetes research. Novo Nordisk extends sponsorship for two years.
Read MoreLegislative and Policy News from September 27, 2017
Nevada’s drug-pricing law faces new court hearing next month.
Read MoreCeliac News from September 27, 2017
Immunopathology of childhood celiac disease—Key role of intestinal epithelial cells. Free full text available in HTML and PDF formats. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease. Free full text available in HTML and PDF formats. Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections. Free full text available in HTML and PDF formats. An In Vitro Fermentation Study on the Effects of Gluten FriendlyTM Bread on Microbiota and Short Chain Fatty Acids of Fecal Samples from Healthy and Celiac Subjects. Free full text available in HTML and PDF formats.
Read MoreDaily Care News from September 27, 2017
Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset. See also Kidney disease ‘virtually universal’ at long durations of type 1 diabetes. See also Kidney disease checks essential in those with long-duration type 1 diabetes, say researchers. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomized controlled trial. Recent Exposure to Hypoglycemia Increases Glucose Variability Following a Hyper/Hypoglycemic Metabolic Challenge in T1D. Could FreeStyle Libre™ sensor glucose data support decisions for safe driving? Type 1 diabetes during adolescence: International comparison between Germany, Austria, and […]
Read MoreResearch News From September 27, 2017
T1D Risk Increased Following Influenza A H1N1 Diagnosis in Children. Childhood body mass index in relation to subsequent risk of type 1 diabetes-A Danish cohort study. Beta Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Nitrate induces a type 1 diabetic profile in alligator hatchlings.
Read MorePopular Press from September 20, 2017
Growing Up With a Parent Who Has Type 1 Diabetes. Woodlands woman uses home to distribute diabetes supplies during Harvey. The designer who weaves clothes with her blood. Rising cost of insulin leads LI diabetics to take dangerous risks. Diabetes spikes among Mississippi children and no one knows why. The diabetic women risking blindness and even death by deliberately NOT taking their insulin to prevent weight gain as they are gripped by a terrifying eating disorder known as diabulimia.
Read MoreCeliac News from September 20, 2017
New Insights into the Pathogenesis of Celiac Disease. Free full text available in HTML and PDF formats. The Nima gluten sensor makes being celiac a whole lot easier.
Read MoreDaily Care News from September 20, 2017
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes. Free full text available in HTML and PDF formats. Eating Frequency and Carbohydrate Intake in Adolescents with Type 1 Diabetes Differ from Those in Their Peers and are Associated with Glycemic Control. Timing of Meal Insulin and Its Relation to Adherence to Therapy in Type 1 Diabetes. Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomized controlled trial. Minidose Glucagon for Exercise-Induced Hypoglycemia […]
Read More